Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China: A Randomized Controlled Trial
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
CONTEXT: Although chronic Helicobacter pylori infection is associated with gastric cancer, the effect of H pylori treatment on prevention of gastric cancer development in chronic carriers is unknown. OBJECTIVE: To determine whether treatment of H pylori infection reduces the incidence of gastric cancer. DESIGN, SETTING, AND PARTICIPANTS: Prospective, randomized, placebo-controlled, population-based primary prevention study of 1630 healthy carriers of H pylori infection from Fujian Province, China, recruited in July 1994 and followed up until January 2002. A total of 988 participants did not have precancerous lesions (gastric atrophy, intestinal metaplasia, or gastric dysplasia) on study entry. INTERVENTION: Patients were randomly assigned to receive H pylori eradication treatment: a 2-week course of omeprazole, 20 mg, a combination product of amoxicillin and clavulanate potassium, 750 mg, and metronidazole, 400 mg, all twice daily (n = 817); or placebo (n = 813). MAIN OUTCOME MEASURES: The primary outcome measure was incidence of gastric cancer during follow-up, compared between H pylori eradication and placebo groups. The secondary outcome measure was incidence of gastric cancer in patients with or without precancerous lesions, compared between the 2 groups. RESULTS: Among the 18 new cases of gastric cancers that developed, no overall reduction was observed in participants who received H pylori eradication treatment (n = 7) compared with those who did not (n = 11) (P =.33). In a subgroup of patients with no precancerous lesions on presentation, no patient developed gastric cancer during a follow-up of 7.5 years after H pylori eradication treatment compared with those who received placebo (0 vs 6; P =.02). Smoking (hazard ratio [HR], 6.2; 95% confidence interval [CI], 2.3-16.5; P<.001) and older age (HR, 1.10; 95% CI, 1.05-1.15; P<.001) were independent risk factors for the development of gastric cancer in this cohort. CONCLUSIONS: We found that the incidence of gastric cancer development at the population level was similar between participants receiving H pylori eradication treatment and those receiving placebo during a period of 7.5 years in a high-risk region of China. In the subgroup of H pylori carriers without precancerous lesions, eradication of H pylori significantly decreased the development of gastric cancer. Further studies to investigate the role of H pylori eradication in participants with precancerous lesions are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,894
Helicobacter pylori Infection and Gastric Carcinoma among Japanese Americans in Hawaii
Nomura, A., Stemmermann, G. N., Chyou, P.-H., Kato, I., Perez-Perez, G. I., & Blaser, M. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251604 · Cited by 1,762
A human model of gastric carcinogenesis.
Corréa, P. (1988) · PubMed · Cited by 1,433
Forman, D., Newell, D. G., Fullerton, F., Yarnell, J. W., Stacey, A. R., Wald, N., & Sitas, F. (1991) · BMJ · doi:10.1136/bmj.302.6788.1302 · Cited by 1,380
An international association between Helicobacter pylori infection and gastric cancer
The EUROGAST Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)90938-d · Cited by 1,155
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
Huang, J.-Q., Sridhar, S., Chen, Y., & Hunt, R. H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70422-6 · Cited by 957
Correa, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1881 · Cited by 737
Uemura, N., Mukai, T., Okamoto, S., Yamaguchi, S., Mashiba, H., Taniyama, K., Sasaki, N., Haruma, K., Sumii, K., & Kajiyama, G. (1997) · PubMed · Cited by 546
Cited by
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Pathogenesis of Helicobacter pylori Infection
Kusters, J. G., van Vliet, A. H. M., & Kuipers, E. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00054-05 · Cited by 2,526
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Epidemiology of gastric cancer
Crew, K. D., & Neugut, A. I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.354 · Cited by 2,108
Cancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk
Wroblewski, L. E., Peek, R. M., & Wilson, K. T. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00011-10 · Cited by 1,442
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
Chey, W. D., Wong, B. C. Y., & Practice Parameters Committee of the American College of Gastroenterology (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01393.x · Cited by 1,406
Self-citationFukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., Terao, S., Amagai, K., Hayashi, S., & Asaka, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61159-9 · Cited by 1,244
Helicobacter pylori: gastric cancer and beyond
Polk, D. B., & Peek, R. M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2857 · Cited by 1,158
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundHe, F. J., & MacGregor, G. A. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2008.144 · Cited by 1,123
Lee, Y.-C., Chiang, T.-H., Chou, C.-K., Tu, Y.-K., Liao, W.-C., Wu, M.-S., & Graham, D. Y. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.028 · Cited by 1,013
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 850
de Vries, A. C., van Grieken, N. C. T., Looman, C. W. N., Casparie, M. K., de Vries, E., Meijer, G. A., & Kuipers, E. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.071 · Cited by 848
The gastric precancerous cascade
CORREA, P., & PIAZUELO, M. B. (2012) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00550.x · Cited by 848
Screening for gastric cancer in Asia: current evidence and practice
Leung, W. K., Wu, M.-S., Kakugawa, Y., Kim, J. J., Yeoh, K.-G., Goh, K. L., Wu, K.-C., Wu, D.-C., Sollano, J., Kachintorn, U., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70072-x · Cited by 822
Inflammation, atrophy, and gastric cancer
Fox, J. G., & Wang, T. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30111 · Cited by 772
Oncogenic mechanisms of the Helicobacter pylori CagA protein
Hatakeyama, M. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1433 · Cited by 752
Carcinogenesis of Helicobacter pylori
Correa, P., & Houghton, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.026 · Cited by 705
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
Ferreira, R. M., Pereira-Marques, J., Pinto-Ribeiro, I., Costa, J. L., Carneiro, F., Machado, J. C., & Figueiredo, C. (2018) · Gut · doi:10.1136/gutjnl-2017-314205 · Cited by 697
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
Choi, I. J., Kook, M.-C., Kim, Y.-I., Cho, S.-J., Lee, J. Y., Kim, C. G., Park, B., & Nam, B.-H. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1708423 · Cited by 673
Reducing population salt intake worldwide: from evidence to implementation
He, F. J., & MacGregor, G. A. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.006 · Cited by 625
Salt Reduction to Prevent Hypertension and Cardiovascular Disease
He, F. J., Tan, M., Ma, Y., & MacGregor, G. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.055 · Cited by 589
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Epidemiology of Stomach Cancer
Brenner, H., Rothenbacher, D., & Arndt, V. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_23 · Cited by 596
Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y., & Moayyedi, P. (2014) · BMJ · doi:10.1136/bmj.g3174 · Cited by 580
THE PATHOGENESIS OF HELICOBACTER PYLORI–INDUCED GASTRO-DUODENAL DISEASES
Atherton, J. C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100125 · Cited by 567
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
Fock, K. M., Katelaris, P., Sugano, K., Ang, T. L., Hunt, R., Talley, N. J., Lam, S. K., Xiao, S., Tan, H. J., Wu, C., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05982.x · Cited by 554
Self-citationHelicobacter infection and gastric neoplasia
Peek, R. M., & Crabtree, J. E. (2006) · The Journal of Pathology · doi:10.1002/path.1868 · Cited by 550
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications
Atherton, J. C., & Blaser, M. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38605 · Cited by 549
Hirota, W. K., Zuckerman, M. J., Adler, D. G., Davila, R. E., Egan, J., Leighton, J. A., Qureshi, W. A., Rajan, E., Fanelli, R., Wheeler-Harbaugh, J., et al. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2006.02.004 · Cited by 528
Smoking and gastric cancer: systematic review and meta-analysis of cohort studies
Ladeiras-Lopes, R., Pereira, A. K., Nogueira, A., Pinheiro-Torres, T., Pinto, I., Santos-Pereira, R., & Lunet, N. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9132-y · Cited by 511
Liou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322368 · Cited by 493
Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma
Tan, P., & Yeoh, K.-G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.059 · Cited by 492
Ford, A. C., Yuan, Y., & Moayyedi, P. (2020) · Gut · doi:10.1136/gutjnl-2020-320839 · Cited by 464
Estimates of Cancer Incidence in China for 2000 and Projections for 2005
Yang, L., Parkin, D. M., Ferlay, J., Li, L., & Chen, Y. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.243.14.1 · Cited by 463
Cheung, K. S., Chan, E. W., Wong, A. Y. S., Chen, L., Wong, I. C. K., & Leung, W. K. (2018) · Gut · doi:10.1136/gutjnl-2017-314605 · Cited by 455
You, W.-C., Brown, L. M., Zhang, L., Li, J.-Y., Jin, M.-L., Chang, Y.-S., Ma, J.-L., Pan, K.-F., Liu, W.-D., Hu, Y., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj264 · Cited by 446
American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia
Talley, N. J., Vakil, N. B., & Moayyedi, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.020 · Cited by 440
Gastric cancer: Prevention, screening and early diagnosis
Pasechnikov, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13842 · Cited by 436
Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection
Liu, W. Z., Xie, Y., Lu, H., Cheng, H., Zeng, Z. R., Zhou, L. Y., Chen, Y., Wang, J. B., Du, Y. Q., Lu, N. H., et al. (2018) · Helicobacter · doi:10.1111/hel.12475 · Cited by 422
Niwa, T., Tsukamoto, T., Toyoda, T., Mori, A., Tanaka, H., Maekita, T., Ichinose, M., Tatematsu, M., & Ushijima, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2755 · Cited by 417
Family History of Gastric Cancer and Helicobacter pylori Treatment
Choi, I. J., Kim, C. G., Lee, J. Y., Kim, Y.-I., Kook, M.-C., Park, B., & Joo, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1909666 · Cited by 407
Pathology of gastric intestinal metaplasia: clinical implications
Correa, P., Piazuelo, B. M., & Wilson, K. T. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.728 · Cited by 405
Characteristics of gastric cancer in Asia
Rahman, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4483 · Cited by 404
The Japanese Guidelines for Gastric Cancer Screening
Hamashima, C., Shibuya, D., Yamazaki, H., Inoue, K., Fukao, A., Saito, H., & Sobue, T. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn017 · Cited by 403
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
Asaka, M., Kato, M., Takahashi, S., Fukuda, Y., Sugiyama, T., Ota, H., Uemura, N., Murakami, K., Satoh, K., & Sugano, K. (2010) · Helicobacter · doi:10.1111/j.1523-5378.2009.00738.x · Cited by 395
THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER
NELSON, W. G., DE MARZO, A. M., DeWEESE, T. L., & ISAACS, W. B. (2004) · Journal of Urology · doi:10.1097/01.ju.0000142058.99614.ff · Cited by 386
The role of gut microbiota in cancer treatment: friend or foe?
Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020) · Gut · doi:10.1136/gutjnl-2020-321153 · Cited by 384
Lofgren, J. L., Whary, M. T., Ge, Z., Muthupalani, S., Taylor, N. S., Mobley, M., Potter, A., Varro, A., Eibach, D., Suerbaum, S., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.048 · Cited by 381
Clinical epidemiology of gastric cancer
Ang, T., & Fock, K. (2014) · Singapore Medical Journal · doi:10.11622/smedj.2014174 · Cited by 380
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Hou, J., Karin, M., & Sun, B. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00459-9 · Cited by 366
Long term follow up of patients treated for Helicobacter pylori infection
Mera, R., Fontham, E. T. H., Bravo, L. E., Bravo, J. C., Piazuelo, M. B., Camargo, M. C., & Correa, P. (2005) · Gut · doi:10.1136/gut.2005.072009 · Cited by 364
Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?
Fuccio, L., Zagari, R. M., Eusebi, L. H., Laterza, L., Cennamo, V., Ceroni, L., Grilli, D., & Bazzoli, F. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-2-200907210-00009 · Cited by 358
Asia–Pacific consensus guidelines on gastric cancer prevention
Fock, K. M., Talley, N., Moayyedi, P., Hunt, R., Azuma, T., Sugano, K., Xiao, S. D., Lam, S. K., Goh, K. L., Chiba, T., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05314.x · Cited by 354
Self-citationLee, Y.-C., Chen, T. H.-H., Chiu, H.-M., Shun, C.-T., Chiang, H., Liu, T.-Y., Wu, M.-S., & Lin, J.-T. (2013) · Gut · doi:10.1136/gutjnl-2012-302240 · Cited by 349
Liu, X., Shao, L., Liu, X., Ji, F., Mei, Y., Cheng, Y., Liu, F., Yan, C., Li, L., & Ling, Z. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.034 · Cited by 322
Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
Park, Y. H., & Kim, N. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.1.25 · Cited by 321
Drosophila lifespan enhancement by exogenous bacteria
Brummel, T., Ching, A., Seroude, L., Simon, A. F., & Benzer, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405207101 · Cited by 317
Watari, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5461 · Cited by 316
AGA clinical practice guidelines on management of gastric intestinal metaplasia
Gupta, S., Li, D., El Serag, H. B., Davitkov, P., Altayar, O., Sultan, S., Falck-Ytter, Y., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.003 · Cited by 320
Evidence‐based Guidelines From ESPGHAN and NASPGHAN for Helicobacter pylori Infection in Children
Koletzko, S., Jones, N. L., Goodman, K. J., Gold, B., Rowland, M., Cadranel, S., Chong, S., Colletti, R. B., Casswall, T., Elitsur, Y., et al. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182227e90 · Cited by 309
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition
Kato, M., Ota, H., Okuda, M., Kikuchi, S., Satoh, K., Shimoyama, T., Suzuki, H., Handa, O., Furuta, T., Mabe, K., et al. (2019) · Helicobacter · doi:10.1111/hel.12597 · Cited by 306
Huang, K. K., Ramnarayanan, K., Zhu, F., Srivastava, S., Xu, C., Tan, A. L. K., Lee, M., Tay, S., Das, K., Xing, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.11.018 · Cited by 294
Eun, C. S., Kim, B. K., Han, D. S., Kim, S. Y., Kim, K. M., Choi, B. Y., Song, K. S., Kim, Y. S., & Kim, J. F. (2014) · Helicobacter · doi:10.1111/hel.12145 · Cited by 292
Helicobacter pylori and gastric carcinogenesis
Hatakeyama, M. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0014-1 · Cited by 291
Mechanisms of Disease: inflammation and the origins of cancer
Moss, S. F., & Blaser, M. J. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0081 · Cited by 291
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study
RUGGE, M., DE BONI, M., PENNELLI, G., DE BONA, M., GIACOMELLI, L., FASSAN, M., BASSO, D., PLEBANI, M., & GRAHAM, D. Y. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04277.x · Cited by 280
Wu, C., Kuo, K. N., Wu, M., Chen, Y., Wang, C., & Lin, J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.060 · Cited by 277
Helicobacter pylori and gastric adenocarcinoma
Herrera, V., & Parsonnet, J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03031.x · Cited by 266
HATAKEYAMA, M. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.013 · Cited by 261
Kim, S. G., Jung, H.-K., Lee, H. L., Jang, J. Y., Lee, H., Kim, C. G., Shin, W. G., Shin, E. S., Lee, Y. C., & Korean College of and Upper Gastrointestinal Research (2013) · The Korean Journal of Gastroenterology · doi:10.4166/kjg.2013.62.1.3 · Cited by 263
Diagnosis and Management of High Risk Group for Gastric Cancer
Yoon, H., & Kim, N. (2015) · Gut and Liver · doi:10.5009/gnl14118 · Cited by 262
Kato, M., Nishida, T., Yamamoto, K., Hayashi, S., Kitamura, S., Yabuta, T., Yoshio, T., Nakamura, T., Komori, M., Kawai, N., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301647 · Cited by 260
Infections and cancer: Established associations and new hypotheses
de Martel, C., & Franceschi, S. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.07.021 · Cited by 258
Greenberg, E. R., Anderson, G. L., Morgan, D. R., Torres, J., Chey, W. D., Bravo, L. E., Dominguez, R. L., Ferreccio, C., Herrero, R., Lazcano-Ponce, E. C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60825-8 · Cited by 257
Chen, H.-N., Wang, Z., Li, X., & Zhou, Z.-G. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0462-7 · Cited by 254
Shichijo, S., Hirata, Y., Niikura, R., Hayakawa, Y., Yamada, A., Ushiku, T., Fukayama, M., & Koike, K. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.03.791 · Cited by 239
AGA technical review on gastric intestinal metaplasia-natural history and clinical outcomes
Gawron, A. J., Shah, S. C., Altayar, O., Davitkov, P., Morgan, D., Turner, K., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.001 · Cited by 175
Bronte-Tinkew, D. M., Terebiznik, M., Franco, A., Ang, M., Ahn, D., Mimuro, H., Sasakawa, C., Ropeleski, M. J., Peek, R. M., & Jones, N. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1191 · Cited by 154
Deciphering the tête-à-tête between the microbiota and the immune system
Surana, N. K., & Kasper, D. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72332 · Cited by 120
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis
VANNELLA, L., LAHNER, E., OSBORN, J., BORDI, C., MIGLIONE, M., DELLE FAVE, G., & ANNIBALE, B. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04268.x · Cited by 110
Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients
Paroni Sterbini, F., Palladini, A., Masucci, L., Cannistraci, C. V., Pastorino, R., Ianiro, G., Bugli, F., Martini, C., Ricciardi, W., Gasbarrini, A., et al. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01437-16 · Cited by 108
Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk
Masuyama, H., Yoshitake, N., Sasai, T., Nakamura, T., Masuyama, A., Zuiki, T., Kurashina, K., Mieda, M., Sunada, K., Yamamoto, H., et al. (2015) · Digestion · doi:10.1159/000368807 · Cited by 101
Toyoshima, O., Yamaji, Y., Yoshida, S., Matsumoto, S., Yamashita, H., Kanazawa, T., & Hata, K. (2017) · Surgical Endoscopy · doi:10.1007/s00464-016-5211-4 · Cited by 59
Kato, M., Hayashi, Y., Nishida, T., Oshita, M., Nakanishi, F., Yamaguchi, S., Kitamura, S., Nishihara, A., Akasaka, T., Ogiyama, H., et al. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15396 · Cited by 33
Mommersteeg, M. C., Eikenboom, E. L., Nieuwenburg, S. A. V., Yu, B., den Hollander, W. J., Holster, I. L., den Hoed, C. M., Capelle, L. G., Tang, T. J., Anten, M.-P., et al. (2021) · Endoscopy International Open · doi:10.1055/a-1314-6626 · Cited by 27
Kuriki, K., Wakai, K., Matsuo, K., Hiraki, A., Suzuki, T., Yamamura, Y., Yamao, K., Nakamura, T., Tatematsu, M., & Tajima, K. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0655 · Cited by 22
Chen, M.-C., Lei, W.-Y., Lin, J.-S., Yi, C.-H., Wu, D.-C., & Hu, C.-T. (2014) · BioMed Research International · doi:10.1155/2014/158520 · Cited by 21
Metadata
- Authors
- Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., Fong, D. Y. T., Ho, J., Ching, C. K., Chen, J. S., & for the China Gastric Cancer Study Group
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-01-14
- Volume
- 291
- Issue
- 2
- Pages
- 187
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2082580119
- Cited by
- 1,435
- References
- 20
- FWCI
- 82.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.